1.1 Alabama State Board of Pharmacy: Structure, Powers, Rulemaking & the 2026 Nine-Member Board

1.1 Alabama State Board of Pharmacy: Structure, Powers, Rulemaking & the 2026 Nine-Member Board

[!NOTE] Statutory Placement & Core Mandate: The practice of pharmacy in Alabama is legally declared a professional practice affecting public health, safety, and welfare. The Alabama State Board of Pharmacy (ALBOP) is established under the Alabama Pharmacy Practice Act (Code of Alabama 1975, Title 34, Chapter 23) and enforces both practice standards and the Alabama Uniform Controlled Substances Act (Ala. Code 1975, Title 20, Chapter 2). Administrative regulations promulgated by the Board are codified under Chapter 680-X of the Alabama Administrative Code (Ala. Admin. Code r. 680-X-1 et seq.).

The Alabama State Board of Pharmacy exercises the state's sovereign police power to regulate individuals and entities engaged in drug distribution, compounding, and patient care. Candidates preparing for the Alabama Multistate Pharmacy Jurisprudence Examination (MPJE) must understand a foundational principle: ALBOP exists solely to protect the health, safety, and welfare of the public, not to promote, protect, or advocate for the economic or professional interests of pharmacists or pharmacies. Professional advocacy is the role of voluntary trade associations, such as the Alabama Pharmacy Association (APA); confusing the regulatory protective function of ALBOP with professional advocacy is a frequent source of examination error.

---

Evolution of Board Composition: Legacy 5-Member Board vs. the Nine-Member Board

For decades ALBOP consisted of five actively practicing pharmacists elected by the profession. The Alabama Legislature changed that with Act 2025-372 (originally House Bill 123), which rewrote Ala. Code § 34-23-90. Under § 34-23-90(b)(1), "[b]eginning January 1, 2026, the board shall consist of nine members who are residents of this state," and Board seats are now appointed by elected officials rather than filled by professional balloting. The Board implemented the change in Ala. Admin. Code r. 680-X-1-.01 (amended effective June 14, 2026).

[!NOTE] Citation hygiene: § 34-23-90 carries a second, later amendment — Act 2026-158, effective June 1, 2026 — so a current code print of the section will show that note. The nine-member expansion itself, however, comes from Act 2025-372 and took effect January 1, 2026. Attributing the expansion to Act 2026-158 is a common error.

The Historical 5-Member Framework (Ala. Code § 34-23-90)

Under the legacy statutory framework codified in Ala. Code § 34-23-90:

• Membership: Exactly five (5) members, all of whom were licensed pharmacists in Alabama.
• Eligibility Criteria: Each member was required to be a resident of Alabama for at least five (5) continuous years immediately preceding appointment, actively engaged in practicing pharmacy or pharmacy administration in the state, and licensed in good standing.
• Appointment Mechanism: Appointed exclusively by the Governor of Alabama. Candidates were nominated through an annual balloting process conducted among licensed pharmacists or submitted via organizational recommendations.
• Term Duration & Limits: Members served staggered five-year terms. No member may serve more than two full terms consecutively (§ 34-23-90(d)) — a limit carried forward to the nine-member board.
• Transition Rule (§ 34-23-90(b)(3), (5)): A member serving on January 1, 2026 continues until that term expires. For the four additional seats beginning January 1, 2026, the Governor set initial staggered terms of two, three, and four years; after those initial terms, every member serves a five-year term beginning January 1 and ending December 31 of the fifth year.

The Nine-Member Board (Ala. Code § 34-23-90(b); Ala. Admin. Code r. 680-X-1-.01)

The Board now seats nine (9) voting members — seven pharmacists, one pharmacy technician, and one consumer. Each pharmacist member must have been licensed in Alabama for a minimum of five years and be actively engaged in the practice or administration of pharmacy; the technician member must be a nationally certified technician registered in Alabama for a minimum of five years and actively practicing as a technician. With one exception, each seat is filled from a list of nominees submitted by a professional association:

1. Hospital Pharmacist (1): Appointed by the Governor from three names submitted by the Alabama Society of Health System Pharmacists.
2. Chain Pharmacist (1): Appointed by the Governor from three names submitted by the Alabama Pharmacy Association.
3. Independent Pharmacist (1): Appointed by the Lieutenant Governor from three names submitted by the Alabama Pharmacy Association.
4. Specialty Pharmacist (1): Nuclear, home infusion, compounding-only, or consultant practice. Appointed by the Speaker of the House from three names submitted by the Alabama Pharmacy Association.
5. Institutional Pharmacist (1): Non-hospital, nursing home, assisted living, or prison practice. Appointed by the President Pro Tempore of the Senate from three names submitted by the Alabama Society of Health System Pharmacists.
6. Academic Pharmacist (1): Appointed by the Lieutenant Governor from a list of four names, two submitted by each of the two Alabama schools of pharmacy. This seat was filled for the first time in March 2026.
7. At-Large Pharmacist (1): Appointed by the Speaker of the House from three names submitted by the Alabama Pharmacy Association.
8. Pharmacy Technician (1): A nationally certified technician registered in Alabama for at least five years. Appointed by the President Pro Tempore of the Senate from three names submitted by the Alabama Pharmacy Association.
9. At-Large Consumer (1): Appointed by the Governor. This is the only seat filled without a nomination list.

[!WARNING] Do not confuse the Board-composition seat labels with the pharmacy classifications in Ala. Admin. Code r. 680-X-2-.05. For permitting purposes (rule .05, repealed and replaced effective July 13, 2026) an independent pharmacy employs fewer than forty (40) full-time-equivalent dispensing pharmacists and is not owned or controlled by a chain corporation, while a chain pharmacy is chain-owned and employs at least 40 FTE dispensing pharmacists across all its locations collectively. The statute defines the Board seats by practice sector, not by a store count.

Distributed Appointing Authorities

To eliminate single-branch executive dominance, Act 2026-158 dispersed appointments among four constitutional officers:

• Governor: Appoints three (3) members (including the public consumer member).
• Lieutenant Governor: Appoints two (2) members.
• Speaker of the House of Representatives: Appoints two (2) members.
• President Pro Tempore of the Senate: Appoints two (2) members.

+---------------------------------------------------------------------------------------------------------+
|                                 ALBOP Governance Structural Comparison                                  |
+---------------------------------------------------------------------------------------------------------+
| Attribute               | Legacy Framework (Pre-2026)          | Act 2026-158 Framework (Effective 2026) |
+-------------------------+--------------------------------------+----------------------------------------+
| Total Voting Members    | 5 Members                            | 9 Members                              |
| Professional Makeup     | 5 Licensed Pharmacists               | 7 Pharmacists, 1 Tech, 1 Consumer      |
| Institutional Rep       | No dedicated institutional seat      | 1 Hospital, 1 Institutional/LTC        |
| Retail Representation   | Undifferentiated retail practice     | Distinct Chain (7+) & Independent (<7) |
| Academic Presence       | Optional/informal                    | 1 Mandatory ACPE Faculty Member        |
| Allied Support Voice    | None                                 | 1 Registered Pharmacy Technician (5+ yr|
| Consumer Representation | None                                 | 1 Unaffiliated Public Consumer Member  |
| Appointing Entity       | Governor exclusively                 | Governor, Lt Gov, Speaker, Sen Pro Tem |
| Term Length             | 5 Years (Staggered)                  | 5 Years (initial 4 seats staggered 2-4)|
| Consecutive Term Limit  | Max 2 full terms                     | Max 2 full terms (§ 34-23-90(d))       |
| Enacting Law            | Acts 1966, Ex. Sess., No. 205 et seq.| Act 2025-372, effective Jan 1, 2026    |
+-------------------------+--------------------------------------+----------------------------------------+

---

Board Leadership: Officers vs. Executive Director

Understanding the legal separation of powers within Board leadership is essential for exam candidates:

Elected Board Officers

• President & Vice President: Annually elected by the voting members of the Board from among their own ranks during the first scheduled meeting of the calendar year.
• Authority: The President presides over official Board meetings, signs formal Board orders resulting from administrative hearings, and appoints internal committees. If the President is absent or incapacitated, the Vice President assumes these duties.

The Executive Director (Ala. Code § 34-23-91)

• Nature of the Role: The Executive Director is the full-time chief administrative officer employed by the Board.
• Non-Member, Non-Voting Status: The Executive Director is an administrative employee, not a member of the Board, and has no vote on regulatory rulemaking, administrative adjudications, or disciplinary penalties.
• Statutory Responsibilities: The Executive Director manages the Board's central office, directs the operational staff, supervises investigators and inspectors, oversees the custody of all official records, administers licensure renewal cycles, executes the Board's operating budget, and liaises with state prosecutors and law enforcement agencies.

[!WARNING] Critical MPJE Distinction: The Executive Director does NOT vote on disciplinary decisions, license suspensions, or rule adoptions. Board members vote; the Executive Director executes and enforces.

---

Regulatory, Rulemaking, Investigatory & Subpoena Powers

ALBOP possesses broad quasi-legislative, quasi-executive, and quasi-judicial authority under Title 34, Chapter 23:

Quasi-Legislative: Administrative Rulemaking

Under the Alabama Administrative Procedure Act (AAPA) (Ala. Code 1975, § 41-22-1 et seq.), the Board can promulgate binding rules codified in Ala. Admin. Code Chapter 680-X. The rulemaking process requires:

1. Formal notice of intended action published in the Alabama Administrative Monthly.
2. A mandatory public notice and comment period of at least 35 calendar days.
3. An open public hearing allowing interested stakeholders to present oral and written testimony.
4. Submission to the legislative Joint Committee on Administrative Regulation Review before final certification.

Quasi-Executive: Licensing, Permitting & Unannounced Inspections

ALBOP issues personal licenses (pharmacists, interns, externs), professional registrations (pharmacy technicians), and institutional facility permits. Facility categories include:

• Retail community pharmacies, institutional hospital pharmacies, and sterile compounding operations.
• Wholesale drug distributors, third-party logistics providers (3PL), manufacturers, repackagers, and 503B outsourcing facilities.

Warrantless Inspection Authority (Ala. Code § 34-23-92): Board investigators and drug inspectors are legally designated officers of the state empowered to enter and inspect any permitted facility or licensed premises:

• No Search Warrant Required: Inspections of permitted pharmacy premises during regular operating hours do not require an administrative or criminal search warrant. By accepting an ALBOP permit or pharmacist license, the licensee provides statutory consent to warrantless inspections.
• Inspection Scope: Inspectors may inspect the entire prescription department, compounding areas, drug storage facilities, inventory logs, compounding records, automated dispensing systems, and all electronic dispensing records.
• Refusal is a Ground for Revocation: Refusing or obstructing an ALBOP inspector conducting an inspection during operating hours is an immediate statutory violation subjecting the pharmacy permit holder and supervising pharmacist to emergency suspension and disciplinary sanctions.

Quasi-Judicial: Subpoenas & Disciplinary Sanctions

When investigating alleged violations of pharmacy statutes or drug diversion, ALBOP possesses the authority to:

• Issue Subpoenas: Subpoena witnesses, administer oaths, and compel the production of books, papers, prescription files, controlled substance logs, and electronic records.
• Administrative Disciplinary Hearings: Adjudicate formal charges under the AAPA, ensuring constitutional due process (written notice of charges, opportunity for legal representation, right to cross-examine witnesses, and standard of substantial evidence).
• Statutory Sanctions: Under Ala. Code § 34-23-33(a) the Board may revoke, suspend, place on probation, or require remediation of a pharmacist license, intern/extern certificate, or pharmacy permit. Section 34-23-33(b) does not itself set a dollar amount; it authorizes the Board to adopt rules imposing a non-disciplinary administrative penalty. The dollar figures therefore live in Board rules — r. 680-X-2-.40 (Non-Disciplinary Penalties), r. 680-X-2-.50 (Civil Penalties), and the penalty schedule in ch. 680-X-A (Appendices, effective October 15, 2026) — where per-violation ranges run up to $5,000 for most personnel and permit violations and up to $10,000 for labeling and recordkeeping violations.

---

Dual Jurisdiction & The Stricter Standard Principle

Pharmacy practice operates under a dual-sovereignty regulatory system involving state agencies (ALBOP, Alabama Department of Public Health [ADPH], Alabama Board of Medical Examiners) and federal agencies (Drug Enforcement Administration [DEA], Food and Drug Administration [FDA], Department of Health and Human Services [HHS]).

When state and federal laws intersect, candidates must apply the Doctrine of the Stricter Standard:

• If federal law establishes a requirement and Alabama law establishes a more stringent requirement, the licensee must obey the stricter Alabama requirement.
• If Alabama law permits an action but federal law restricts or prohibits it, federal law prevails, and the licensee must obey the stricter federal restriction.
• Federal preemption only displaces state pharmacy law when there is an irreconcilable conflict such that compliance with both is physically impossible, or when Congress has explicitly occupied the entire regulatory field.

Applied Jurisdiction Matrix